Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Total 13F shares
-
57,257,345
-
Share change
-
-369,161
-
Total reported value
-
$1,315,213,956
-
Put/Call ratio
-
181%
-
Price per share
-
$22.97
-
Number of holders
-
159
-
Value change
-
-$9,971,782
-
Number of buys
-
76
-
Number of sells
-
68
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q1 2023
As of 31 Mar 2023,
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,257,345 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Bellevue Group AG, ARMISTICE CAPITAL, LLC, STATE STREET CORP, Rock Springs Capital Management LP, FARALLON CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, and FIRST TRUST ADVISORS LP.
This page lists
160
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.